Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

February 10, 2023

Study Completion Date

May 10, 2023

Conditions
Primary HyperaldosteronismPrimary Hyperaldosteronism Due to Adrenal Adenoma
Interventions
PROCEDURE

Endoscopic ultrasound guided radiofrequency ablation

To establish if radiofreuqency ablation of aldosterone producing adrenal adenomas can be carried out via the endoscopic route and to assess safety of the procedure.

DEVICE

ultrasound

ultrasound

Trial Locations (3)

Unknown

University of Cambridge and Cambridge NIHR Biomedical Research Centre, Cambridge

EC1M 6BQ

Queen Mary University of London, London

NW3 2QG

University College London, London

All Listed Sponsors
collaborator

Queen Mary University of London

OTHER

collaborator

British Heart Foundation

OTHER

collaborator

University of Cambridge

OTHER

collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Barts & The London NHS Trust

OTHER

collaborator

University College London Hospitals

OTHER

lead

University College, London

OTHER

NCT03405025 - Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas | Biotech Hunter | Biotech Hunter